Mechanistic Study and Therapeutic Strategy of HDAC6 Regulates EGFR Signaling in Hepatocellular Carcinoma

碩士 === 輔英科技大學 === 醫學檢驗生物技術系碩士班 === 102 === In Taiwan, hepatocellular carcinoma (HCC) is the second most common cause of cancer death and causes more than 7,500 deaths each year. Nevertheless, approximately 75% of patients with HCC have advanced unresectable diseases upon presentation. Alterations of...

Full description

Bibliographic Details
Main Authors: Hong-Ying Dai, 戴宏穎
Other Authors: Yao-Tsung Yeh
Format: Others
Language:zh-TW
Published: 2014
Online Access:http://ndltd.ncl.edu.tw/handle/19778475173548538156